Is PAIOF or DGRO a better dividend investment in 2026?

PAIOF currently yields 20000.00% with a 5% 5-year dividend growth rate. DGRO yields 2.13% with 9.5% growth. The better choice depends on your goal: PAIOF offers higher current income.

What is the dividend yield difference between PAIOF and DGRO?

PAIOF has a forward dividend yield of 20000.00% ($2.00/share annually). DGRO yields 2.13% ($1.47/share annually). The yield gap is 19997.87 percentage points.

Home › Compare › PAIOF vs DGRO

PAIOF vs DGRO: Dividend Comparison 2026

PAIOF yields 20000.00% · DGRO yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PAIOF wins by $52481917574412746752.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PAIOF

● Live price

20000.00%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$52481917574412746752.00M

Annual income

$51,970,745,957,167,775,000,000,000.00

Full PAIOF calculator →

DGRO

iShares Core Dividend Growth ETF

● Live price

2.13%

Share price

$68.98

Annual div

$1.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.6K

Annual income

$239.96

Full DGRO calculator →

Portfolio growth — PAIOF vs DGRO

📍 PAIOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PAIOF	DGRO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PAIOF + DGRO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PAIOF pays

DGRO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PAIOF

Annual income on $10K today (after 15% tax)

$1,700,000.00/yr

After 10yr DRIP, annual income (after tax)

$44,175,134,063,592,610,000,000,000.00/yr

DGRO

Annual income on $10K today (after 15% tax)

$181.24/yr

After 10yr DRIP, annual income (after tax)

$203.97/yr

At 15% tax rate, PAIOF beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PAIOF + DGRO for your $10,000?

PAIOF: 50%DGRO: 50%

100% DGRO50/50100% PAIOF

Portfolio after 10yr

$26240958787206373376.00M

Annual income

$25,985,372,978,583,888,000,000,000.00/yr

Blended yield

99.03%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PAIOF buys

DGRO buys

No recent congressional trades found for PAIOF or DGRO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPAIOFDGRO

Forward yield	20000.00% ✓	2.13%
Annual dividend / share	$2.00 ✓	$1.47
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$52481917574412746752.00M ✓	$31.6K
Annual income after 10y	$51,970,745,957,167,775,000,000,000.00 ✓	$239.96
Total dividends collected	$52448189483771600896.00M ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: PAIOF vs DGRO ($10,000, DRIP)

Year	PAIOF Portfolio	PAIOF Income/yr	DGRO Portfolio	DGRO Income/yr	Gap
1← crossover	$2,010,700	$2,000,000.00	$11,293	$213.22	+$2.00M → PAIOF
2	$377,983,225	$375,831,775.70	$12,730	$217.32	+$377.97M → PAIOF
3	$66,433,479,469	$66,029,037,418.28	$14,326	$221.10	+$66433.47M → PAIOF
4	$10,916,985,471,987	$10,845,901,648,955.73	$16,098	$224.56	+$10916985.46M → PAIOF
5	$1,677,384,363,769,318	$1,665,703,189,314,291.80	$18,064	$227.74	+$1677384363.75M → PAIOF
6	$240,985,175,079,139,100	$239,190,373,809,905,920.00	$20,246	$230.65	+$240985175079.12M → PAIOF
7	$32,373,573,631,143,694,000	$32,115,719,493,809,017,000.00	$22,666	$233.30	+$32373573631143.67M → PAIOF
8	$4,066,766,648,320,630,000,000	$4,032,126,924,535,306,000,000.00	$25,349	$235.73	+$4066766648320630.00M → PAIOF
9	$477,730,483,406,513,300,000,000	$473,379,043,092,810,300,000,000.00	$28,325	$237.94	+$477730483406513344.00M → PAIOF
10	$52,481,917,574,412,750,000,000,000	$51,970,745,957,167,775,000,000,000.00	$31,624	$239.96	+$52481917574412746752.00M → PAIOF

PAIOF vs DGRO: Complete Analysis 2026

PAIOF — Stock

Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation. It is also developing Angiotensin II, a vasoconstrictor indicated for the treatment of refractory hypotension in adults with septic or other distributive shock; and Eravacycline, a novel fluorocycline antibiotic indicated for the treatment of complicated intra-abdominal infections in adults. The company has partnerships and license agreements with Cosmo Pharmaceuticals, Wuhan Humanwell Innovative Drug Research and Development Center Limited Company, Hana Pharm, Yichang Humanwell, and Mundipharma. Paion AG was founded in 2000 and is based in Aachen, Germany.

Full PAIOF Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →

📬

Get this PAIOF vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PAIOF vs SCHD PAIOF vs JEPI PAIOF vs O PAIOF vs KO PAIOF vs MAIN PAIOF vs VIG PAIOF vs NOBL PAIOF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.